Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2025 07:00 ET | Source: Gyre Therapeutics Inc.

Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology

Gyre Announces Publication of Protocol for Phase 3 Trial of F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology
March 17, 2025 16:15 ET | Source: Gyre Therapeutics Inc.

Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
January 06, 2025 07:00 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors
November 13, 2024 06:00 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
October 22, 2024 16:05 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
October 01, 2024 16:05 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
September 04, 2024 16:05 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 13, 2024 06:00 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
August 08, 2024 16:05 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
June 18, 2024 16:05 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology

Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology

Next Page keyboard_arrow_right